Skip to main content
رجوع
UHS logo

Universal Health Services, Inc.

جودة البيانات: 100%
UHS
NYSE Healthcare Medical - Care Facilities
KWD 186.72
▲ KWD 0.80 (0.43%)
القيمة السوقية: 11.87B
نطاق اليوم
KWD 182.47 KWD 188.56
نطاق 52 أسبوعًا
KWD 152.33 KWD 246.33
حجم التداول
510,713
متوسط 50 يوم / 200 يوم
KWD 207.33 / KWD 200.41
الإغلاق السابق
KWD 185.92

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 8.0 0.2
P/B 1.6 3.0
ROE % 21.4 3.6
Net Margin % 8.6 3.8
Rev Growth 5Y % 8.3 9.9
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 245.67 +31.6%
Low: KWD 219.00 High: KWD 274.00
مكرر الربحية المستقبلي
7.96
ربحية السهم المستقبلية
KWD 23.44
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
18.48B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 28.77
KWD 27.74 – KWD 29.24
20.54B 4
FY2028 KWD 28.25
KWD 26.68 – KWD 31.03
20.33B 6
FY2027 KWD 25.57
KWD 23.79 – KWD 28.09
19.39B 11

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-25 KWD 5.86 KWD 5.88 +0.3%
2025-10-27 KWD 4.66 KWD 5.69 +22.1%
2025-07-28 KWD 4.92 KWD 5.35 +8.7%
2025-04-28 KWD 4.35 KWD 4.84 +11.3%
2025-02-26 KWD 4.21 KWD 4.92 +16.9%
2024-10-24 KWD 3.65 KWD 3.71 +1.6%
2024-07-24 KWD 3.28 KWD 4.31 +31.4%
2024-04-24 KWD 3.15 KWD 3.70 +17.5%

Dividend History

7 yr streak

Yield

0.00%

Payout Ratio

0.03%

Growth (3Y)

0.00%

Growth (5Y)

31.95%

Ex-Date Payment Date Amount Yield
Mar 02, 2026 Mar 16, 2026 KWD 0.20 0.39%
Dec 01, 2025 Dec 15, 2025 KWD 0.20 0.33%
Sep 02, 2025 Sep 16, 2025 KWD 0.20 0.44%
Jun 02, 2025 Jun 16, 2025 KWD 0.20 0.43%
Mar 03, 2025 Mar 17, 2025 KWD 0.20 0.46%
Dec 03, 2024 Dec 17, 2024 KWD 0.20 0.40%
Sep 03, 2024 Sep 17, 2024 KWD 0.20 0.34%
Jun 03, 2024 Jun 17, 2024 KWD 0.20 0.43%
Feb 29, 2024 Mar 15, 2024 KWD 0.20 0.48%
Nov 30, 2023 Dec 15, 2023 KWD 0.20 0.58%
Aug 31, 2023 Sep 15, 2023 KWD 0.20 0.59%
May 31, 2023 Jun 15, 2023 KWD 0.20 0.61%
Feb 28, 2023 Mar 15, 2023 KWD 0.20 0.60%
Nov 30, 2022 Dec 15, 2022 KWD 0.20 0.61%
Aug 31, 2022 Sep 15, 2022 KWD 0.20 0.82%
May 31, 2022 Jun 15, 2022 KWD 0.20 0.64%
Feb 28, 2022 Mar 15, 2022 KWD 0.20 0.56%
Nov 30, 2021 Dec 15, 2021 KWD 0.20 0.67%
Aug 31, 2021 Sep 15, 2021 KWD 0.20 0.39%
Jun 01, 2021 Jun 17, 2021 KWD 0.20 0.25%

النقاط الرئيسية

Revenue grew 8.26% annually over 5 years — modest growth
Earnings grew 30.36% over the past year
ROE of 21.36% indicates high profitability
Generating 849.25M in free cash flow
P/E of 7.97 — trading at a low valuation
PEG of 0.26 suggests growth is underpriced

النمو

Revenue Growth (5Y)
8.26%
Revenue (1Y)9.71%
Earnings (1Y)30.36%
FCF Growth (3Y)27.22%

الجودة

Return on Equity
21.36%
ROIC11.70%
Net Margin8.57%
Op. Margin11.48%

الأمان

Debt / Equity
0.76
Current Ratio1.05
Interest Coverage12.68

التقييم

P/E Ratio
7.97
Forward P/E7.96
P/B Ratio1.63
EV/EBITDA8.65
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9.71% Revenue Growth (3Y) 10.27%
Earnings Growth (1Y) 30.36% Earnings Growth (3Y) 44.02%
Revenue Growth (5Y) 8.26% Earnings Growth (5Y) 10.69%
Profitability
Revenue (TTM) 17.36B Net Income (TTM) 1.49B
ROE 21.36% ROA 9.33%
Gross Margin 90.45% Operating Margin 11.48%
Net Margin 8.57% Free Cash Flow (TTM) 849.25M
ROIC 11.70% FCF Growth (3Y) 27.22%
Safety
Debt / Equity 0.76 Current Ratio 1.05
Interest Coverage 12.68
Dividends
Dividend Yield 0.00% Payout Ratio 0.03%
Dividend Growth (3Y) 0.00% Dividend Growth (5Y) 31.95%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 7.97 Forward P/E 7.96
P/B Ratio 1.63 P/S Ratio 0.68
PEG Ratio 0.26 Forward PEG N/A
EV/EBITDA 8.65 Fwd EV/EBITDA 6.76
Forward P/S 0.64 Fwd Earnings Yield 12.56%
FCF Yield 7.15%
Market Cap 11.87B Enterprise Value 17.24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 17.36B 15.83B 14.28B 13.40B 12.64B
Net Income 1.49B 1.14B 717.80M 675.61M 991.59M
EPS (Diluted) 23.10 16.82 10.23 9.14 11.82
Gross Profit 15.71B 14.24B 12.75B 11.93B 11.21B
Operating Income 1.99B 1.68B 1.18B 1.00B 1.36B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.96B 14.47B 13.97B 13.49B 13.09B
Total Liabilities 8.55B 7.71B 7.77B 7.52B 6.90B
Shareholders' Equity 7.28B 6.67B 6.15B 5.92B 6.09B
Total Debt 5.51B 4.96B 5.37B 5.27B 4.56B
Cash & Equivalents 137.80M 125.98M 119.44M 102.82M 115.30M
Current Assets 3.41B 2.82B 2.81B 2.54B 2.26B
Current Liabilities 3.24B 2.21B 2.01B 1.91B 1.98B

درجات الاستراتيجيات

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
#377 of 619
28
Custom Balanced Risk
#150 of 153
23
Custom Lower Risk
#133 of 141
27

النشاط الأخير

خرج Contrarian Investing (David Dreman)
Mar 26, 2026
دخل Contrarian Investing (David Dreman)
Mar 25, 2026
دخل Balanced Risk
Mar 25, 2026
دخل Lower Risk
Mar 25, 2026
دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026